eMedicine Specialties > Neurology > Neurological Infections

HIV-1 Associated CNS Conditions - Meningitis

Author: Niranjan N Singh, MD, DNB, Assistant Professor of Neurology, University of Missouri Columbia
Coauthor(s): Florian P Thomas, MD, MA, PhD, Drmed,, Director, Spinal Cord Injury Service, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Director, Neuropathy Association Center of Excellence, Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Contributor Information and Disclosures

Updated: Feb 23, 2010

Introduction

Background

Different forms of meningitis are associated with HIV infection. They may be classified according to the etiologic agent as cryptococcal, tuberculous, syphilitic, or Listeria species; others are lymphomatous or aseptic.

Pathophysiology

Meningitis is multifactorial in patients with HIV/AIDS. Besides specific pathogens, autoimmune processes and HIV itself have been implicated.

Although HIV-seropositive individuals are at increased risk of certain types of meningitis, evidence suggests that they are also more likely than the general population to develop community-acquired bacterial or viral meningitides. An early form of aseptic, HIV-associated meningitis develops within days to weeks after HIV infection. It appears as a mononucleosis-like illness and is rarely associated with encephalitis. Meningitides due to cryptococcosis, coccidioidomycosis, histoplasmosis, or other fungal infection are AIDS-defining events and occur typically with very low CD4+ lymphocyte counts.

Chronic meningitis or episodes of acute meningitis for which no cause is found can occur anytime during the disease course.

An asymptomatic form is found in one third of patients in whom CSF is examined for other reasons (eg, headache).

Cytomegaloviral (CMV) infection usually presents as an encephaloventriculitis with possible meningeal involvement.

Medications as causes are often overlooked including nonsteroidal anti-inflammatory drugs (NSAIDs), trimethoprim/sulfamethoxazole, and intravenous immunoglobulin (IVIG).

In patients receiving highly active anti-retroviral therapy (HAART) and a syndrome of relapsing remitting meningitis with negative cultures and atypical signs and symptoms, consider immune reconstitution inflammatory syndrome (IRIS). This is regarded as an overactive response of a newly reconstituted immune system to infectious agents already present in the patient when the therapy is started. Symptoms that are consistent with an infectious and/or inflammatory condition appear while the patient is on antiretroviral therapy and the symptoms cannot be explained by a new or a previous infection or by the side effects of the therapy. It has been proposed that IRIS is due to an imbalance of CD8+/CD4+ cells.

Frequency

United States

Cryptococcal meningitis is the most common opportunistic infection of the CNS, affecting 5-7% of patients with AIDS. The second most common type of meningitis is aseptic meningitis, which may be caused by HIV-1 itself.

Rarer CNS infections are due to Listeria monocytogenes, coccidioidomycosis, histoplasmosis, syphilis, and tuberculosis. CNS syphilis may occur earlier and more frequently in HIV-seropositive individuals than in HIV-seronegative individuals.

Bacterial meningitis often occurs in conjunction with sepsis due to the same organism.

In rare cases, metastatic CNS lymphoma can appear as meningitis.

Mortality/Morbidity

Mortality rates and morbidity vary by the etiology of meningitis. A previously reported mortality rate of 20% for cryptococcal meningitis, for example, may now be as low as 6% owing to more aggressive therapy. Higher mortality rates correlate with poor mental status, high CSF opening pressure at presentation, positive India ink test, extra-CNS manifestations, and higher fungal burdens.

Clinical

History

In general, symptoms and signs typically associated with meningitis are less likely to occur in HIV-seropositive individuals than in the general population. This probably reflects the different organisms involved and the differences in immune responses.

One meta-analysis showed that stiff neck occurred in 50% of cases of non-AIDS meningitis; four studies shoed rates of 22%, 31%, 37%, and 44% for AIDS meningitis. Similarly, the frequency of papilledema was 28% in that same study of non-AIDS meningitis, whereas frequencies of 6% and 8% were reported in 2 studies of AIDS meningitis.

Characteristics of HIV-seropositive patients with meningitis are the following:

  • Patients present with malaise, fever, stiff neck, photophobia, and headache.
  • Less common findings are confusion, somnolence, and personality changes.
  • The time course is variable. Patients with aseptic meningitis, a diagnosis of exclusion, have a good prognosis and do not require any specific treatment.
  • Cryptococcal meningitis can occur acutely, with severe headache, change in mental status, fever, nuchal rigidity, and focal signs, or with a subacute course of malaise and headache without stiff neck over several weeks. Sometimes Cryptococcus neoformans is incidentally found in the CSF.
  • CMV ventriculoencephalitis often causes death within weeks to months. It usually results in a change in mental status evolving over several weeks and can be misdiagnosed as HIV-associated dementia

Physical

  • Examination can reveal nuchal rigidity, fever, and cranial neuropathies.
  • In rare cases, the patient is somnolent or confused.

More on HIV-1 Associated CNS Conditions - Meningitis

Overview: HIV-1 Associated CNS Conditions - Meningitis
Differential Diagnoses & Workup: HIV-1 Associated CNS Conditions - Meningitis
Treatment & Medication: HIV-1 Associated CNS Conditions - Meningitis
Follow-up: HIV-1 Associated CNS Conditions - Meningitis
References

References

  1. Bicanic T, Wood R, Meintjes G, Rebe K, Brouwer A, Loyse A. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis. Jul 1 2008;47(1):123-30. [Medline].

  2. Longley N, Muzoora C, Taseera K, Mwesigye J, Rwebembera J, Chakera A, et al. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. Clin Infect Dis. Dec 15 2008;47(12):1556-61. [Medline].

  3. Antinori S, Radice A, Galimberti L. The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis. J Clin Microbiol. Nov 2005;43(11):5828-9. [Medline].

  4. De Gans J, Portegies P. Neurological complications of infection with human immunodeficiency virus type 1: a review of literature and 241 cases. Clin Neurol Neurosurg. 1989;91:199-219. [Medline].

  5. Gendelman HE, Lipton SA, Epstein L. The Neurology of AIDS. New York, NY: Chapman and Hall;. 1998.

  6. Geraci AP, Simpson DM. Neurological manifestations of HIV-1 infection in the HAART era. Compr Ther. 2001;27(3):232-41. [Medline].

  7. Klepser ME, Klepser TB. Drug treatment of HIV-related opportunistic infections. Drugs. Jan 1997;53(1):40-73. [Medline].

  8. Moussa R, Stephenson I, Fisk P, et al. Buschke-Loewenstein lesion: another possible manifestation of immune restoration inflammatory syndrome?. AIDS. May 21 2004;18(8):1221-3. [Medline].

  9. Price RW. Neurological complications of HIV infection. Lancet. Aug 17 1996;348(9025):445-52. [Medline].

  10. Saag MS. Cryptococcosis and other fungal infections (Histoplasmosis, Coccidiomycosis). In: Sande MA, Volberding PA, eds. The medical management of AIDS. 6th ed. Philadelphia, PA: WB Saunders;. 1999: 361-70.

  11. Saag MS, Graybill RJ, Larsen RA. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. Apr 2000;30(4):710-8. [Medline].

  12. Said G, Saimont AG, Lacroix C. Neurological complications of HIV and AIDS. Philadelphia, PA: WB Saunders;. 1998.

  13. Schwarz P, Janbon G, Dromer F. Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans. Antimicrob Agents Chemother. Jan 2007;51(1):383-5. [Medline].

  14. Sloan D, Dlamini S, Paul N, Dedicoat M. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev. 2008;(4):CD005647. [Medline].

  15. Vendrely A, Bienvenu B, Gasnault J. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl). Apr 2005;109(4):449-55. [Medline].

  16. Verma A. Neurological manifestations of human immunodeficiency virus infection in adults. Neurol Clin Pract. 2004;2:1581-602.

  17. Whitley RJ, Jacobson MA, Friedberg DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. May 11 1998;158(9):957-69. [Medline].

Further Reading

Keywords

acquired immunodeficiency syndrome, AIDS, cryptococcal meningitis, tuberculous meningitis, syphilitic meningitis, Listeria species, lymphomatous meningitis, aseptic meningitis, cryptococcosis, coccidioidomycosis, histoplasmosis, CMV, cytomegalovirus, CNS infections in HIV, Listeria monocytogenes, histoplasmosis, syphilis, tuberculosis, CNS syphilis, bacterial meningitis

Contributor Information and Disclosures

Author

Niranjan N Singh, MD, DNB, Assistant Professor of Neurology, University of Missouri Columbia
Niranjan N Singh, MD, DNB is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Coauthor(s)

Florian P Thomas, MD, MA, PhD, Drmed,, Director, Spinal Cord Injury Service, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Director, Neuropathy Association Center of Excellence, Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Florian P Thomas, MD, MA, PhD, Drmed, is a member of the following medical societies: American Academy of Neurology, American Neurological Association, American Paraplegia Society, and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

Medical Editor

Ronald A Greenfield, MD, Professor, Department of Internal Medicine, Section of Infectious Diseases, University of Oklahoma College of Medicine
Ronald A Greenfield, MD is a member of the following medical societies: American College of Physicians, American Federation for Medical Research, American Society for Microbiology, Central Society for Clinical Research, Infectious Diseases Society of America, Medical Mycology Society of the Americas, Phi Beta Kappa, Southern Society for Clinical Investigation, and Southwestern Association of Clinical Microbiology
Disclosure: Pfizer Honoraria Speaking and teaching; Gilead Honoraria Speaking and teaching; Ortho McNeil Honoraria Speaking and teaching; Wyeth Honoraria Speaking and teaching; Abbott Honoraria Speaking and teaching; Astellas Honoraria Speaking and teaching; Cubist  Speaking and teaching

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale
Richard J Caselli, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, American Neurological Association, and Sigma Xi
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.